|
||||||||||||||||||
|
|
||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe GK1.5 monoclonal antibody reacts with the mouse CD4 molecule, a 55 kDa cell surface receptor expressed by a majority of thymocytes, subpopulation of mature T cells and dendritic cells. CD4 binds to MHC class II on the surface of antigen presenting cells and plays an important role both in T cell development and in optimal functioning of mature T cells. In T cells, CD4 associates with protein tyrosine kinase p56lck through its cytoplasmic tail. Binding of GK1.5 is blocked by RM4-5. Applications ReportedFor research use only, not for diagnostic or therapeutic use. This GK1.5 antibody has been reported for use in flow cytometric analysis, immunoprecipitation, and immunohistochemical staining of frozen tissue sections. It has also been reported in isolation and depletion of CD4+ cells, and for blocking of CD4-ligand binding and T cell activation that occurs through CD4. Applications TestedThis GK1.5 antibody has been tested by flow cytometric analysis of mouse thymocytes and splenocytes. This can be used at less than or equal to 0.125 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
Mochimaru H, Usui T, Yaguchi T, Nagahama Y, Hasegawa G, Usui Y, Shimmura S, Tsubota K, Amano S, Kawakami Y, Ishida S. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2. Invest Ophthalmol Vis Sci. 2008 May;49(5):2172-7. (GK1.5, in vivo depletion, PubMed) Yang Z, Day YJ, Toufektsian MC, Xu Y, Ramos SI, Marshall MA, French BA, Linden J. Myocardial infarct-sparing effect of adenosine A2A receptor activation is due to its action on CD4+ T lymphocytes. Circulation. 2006 Nov 7;114(19):2056-64. (GK1.5, in vivo depletion, PubMed) Dialynas DP, Quan ZS, Wall KA, Pierres A, Quintáns J, Loken MR, Pierres M, Fitch FW. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol. 1983 Nov;131(5):2445-51. Wilde DB, Marrack P, Kappler J, Dialynas DP, Fitch FW. Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen- specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines. J Immunol. 1983 Nov;131(5):2178-83. Related ProductsCat. 11-0042 FITC anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 12-0042 PE anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 13-0042 Biotin anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 14-0042 Affinity Purified anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 15-0042 PE-Cy5 anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 16-0042 Functional Grade Purified anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 17-0042 APC anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 25-0042 PE-Cy7 anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 30-0042 Allophycocyanin-Cy5.5 (APC-Cy5.5) anti-mouse CD4 (L3T4) (Alexa Fluor® 700 Equivalent) (clone RM4-5) Cat. 35-0042 PE-Cy5.5 anti-mouse CD4 (L3T4) (clone RM4-5) Cat. 11-0043 Fluorescein isothiocyanate (FITC) anti-mouse CD4 (L3T4) (clone RM4-4) Cat. 12-0043 Phycoerythrin (PE) anti-mouse CD4 (L3T4) (clone RM4-4) Cat. 13-0043 Biotin anti-mouse CD4 (L3T4) (clone RM4-4) Cat. 14-0043 Affinity Purified anti-mouse CD4 (L3T4) (clone RM4-4) Cat. 36-4031 In Vivo Cytokine Capture Assay (IVCCA) In Vivo Capture Antibody – Control / Functional Grade Biotin Rat IgG2b Isotype Control |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |